Search research articles
Contact Us
Filters
Showing results (31-40 of 50) with videos related to
Page
of 5
Sort By:
British Journal of Haematology
|
March 4, 2014
Everolimus for patients with mantle cell lymphoma refractory to or intolerant of bortezomib: multicentre, single-arm, phase 2 study
Michael Wang, Leslie L Popplewell, Robert H Collins, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 11, 2008
Intermittent target inhibition with dasatinib 100 mg once daily preserves efficacy and improves tolerability in imatinib-resistant and -intolerant chronic-phase chronic myeloid leukemia
Neil P Shah, Hagop M Kantarjian, Dong-Wook Kim, et al.
The New England Journal of Medicine
|
May 10, 2013
Oncogenic CSF3R mutations in chronic neutrophilic leukemia and atypical CML
Julia E Maxson, Jason Gotlib, Daniel A Pollyea, et al.
Blood
|
September 5, 2021
Identification and prioritization of myeloid malignancy germline variants in a large cohort of adult patients with AML
Fei Yang, Nicola Long, Tauangtham Anekpuritanang, et al.
Cancer Discovery
|
January 9, 2025
Nonselective β-Adrenergic Receptor Inhibitors Impair Hematopoietic Regeneration in Mice and Humans after Hematopoietic Cell Transplants
Jinsuke Nishino, Wenhuo Hu, Ashwin Kishtagari, et al.
Blood Advances
|
October 9, 2020
Telomere biology disorder prevalence and phenotypes in adults with familial hematologic and/or pulmonary presentations
Simone Feurstein, Ayodeji Adegunsoye, Danijela Mojsilovic, et al.
Cancer Discovery
|
October 12, 2022
Disabling Uncompetitive Inhibition of Oncogenic IDH Mutations Drives Acquired Resistance
Junhua Lyu, Yuxuan Liu, Lihu Gong, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 28, 2019
Efficacy of Ruxolitinib in Patients With Chronic Neutrophilic Leukemia and Atypical Chronic Myeloid Leukemia
Kim-Hien T Dao, Jason Gotlib, Michael M N Deininger, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
February 23, 2024
Chronic Myeloid Leukemia, Version 2.2024, NCCN Clinical Practice Guidelines in Oncology
Neil P Shah, Ravi Bhatia, Jessica K Altman, et al.
Blood
|
August 2, 2019
Genomic landscape of neutrophilic leukemias of ambiguous diagnosis
Haijiao Zhang, Beth Wilmot, Daniel Bottomly, et al.
Page
of 5
Search research articles
Search
Showing results (31-40 of 50) with videos related to
Sort By:
Page
of 5
British Journal of Haematology
|
March 4, 2014
Everolimus for patients with mantle cell lymphoma refractory to or intolerant of bortezomib: multicentre, single-arm, phase 2 study
Michael Wang, Leslie L Popplewell, Robert H Collins, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 11, 2008
Intermittent target inhibition with dasatinib 100 mg once daily preserves efficacy and improves tolerability in imatinib-resistant and -intolerant chronic-phase chronic myeloid leukemia
Neil P Shah, Hagop M Kantarjian, Dong-Wook Kim, et al.
The New England Journal of Medicine
|
May 10, 2013
Oncogenic CSF3R mutations in chronic neutrophilic leukemia and atypical CML
Julia E Maxson, Jason Gotlib, Daniel A Pollyea, et al.
Blood
|
September 5, 2021
Identification and prioritization of myeloid malignancy germline variants in a large cohort of adult patients with AML
Fei Yang, Nicola Long, Tauangtham Anekpuritanang, et al.
Cancer Discovery
|
January 9, 2025
Nonselective β-Adrenergic Receptor Inhibitors Impair Hematopoietic Regeneration in Mice and Humans after Hematopoietic Cell Transplants
Jinsuke Nishino, Wenhuo Hu, Ashwin Kishtagari, et al.
Blood Advances
|
October 9, 2020
Telomere biology disorder prevalence and phenotypes in adults with familial hematologic and/or pulmonary presentations
Simone Feurstein, Ayodeji Adegunsoye, Danijela Mojsilovic, et al.
Cancer Discovery
|
October 12, 2022
Disabling Uncompetitive Inhibition of Oncogenic IDH Mutations Drives Acquired Resistance
Junhua Lyu, Yuxuan Liu, Lihu Gong, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 28, 2019
Efficacy of Ruxolitinib in Patients With Chronic Neutrophilic Leukemia and Atypical Chronic Myeloid Leukemia
Kim-Hien T Dao, Jason Gotlib, Michael M N Deininger, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
February 23, 2024
Chronic Myeloid Leukemia, Version 2.2024, NCCN Clinical Practice Guidelines in Oncology
Neil P Shah, Ravi Bhatia, Jessica K Altman, et al.
Blood
|
August 2, 2019
Genomic landscape of neutrophilic leukemias of ambiguous diagnosis
Haijiao Zhang, Beth Wilmot, Daniel Bottomly, et al.
Page
of 5